Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for infection prevention in emergency cesarean section
ACTRN12619000018112Phase 4Not yet recruiting
- Sponsor
- Redland Hospital
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of azithromycin in surgical site infection (SSI), endometritis and postpartum sepsis (2 arms), sponsored by Redland Hospital. Primary endpoint: Infection rates. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
surgical site infection (SSI)endometritispostpartum sepsis
Beyond the preview
Go deeper on ACTRN12619000018112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000018112.